tirzepatide dose for diabetes Big update in pediatric care 🩺 Mounjaro® (tirzepatide) is now FDA-approved children ≥10 years old with Type 2 diabetes as an adjunct to diet and exercise. What this means ⬇️ Switching from semaglutide to tirzepatide

Food marketing, larger portions, and the prevalence of high-calorie, low-nutrient options contribute to overeating

Proposed mechanisms include reduced postprandial glucose excursions, potentially through delayed glucose absorption and modest increases in endogenous GLP-1 secretion, though human evidence remains limited and of low certainty

Acute liver failure: redefining the syndromes

UK Evidence and Safety Guide Ozempic (semaglutide) is a once-weekly injectable medication licensed in the UK for treating type 2 diabetes in adults

Diverticulitis is not listed as a known adverse effect in the Summary of Product Characteristics (SmPC) for Wegovy, nor has it been identified as a safety signal in post-marketing surveillance by the MHRA or EMA